Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Daiichi Sankyo
Argus Health
Teva
McKinsey
Fish and Richardson

Generated: March 18, 2019

DrugPatentWatch Database Preview

LEVOXYL Drug Profile

« Back to Dashboard

Which patents cover Levoxyl, and when can generic versions of Levoxyl launch?

Levoxyl is a drug marketed by King Pharms and is included in one NDA. There are three patents protecting this drug.

This drug has twenty-six patent family members in nine countries.

The generic ingredient in LEVOXYL is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

Drug patent expirations by year for LEVOXYL
Pharmacology for LEVOXYL
Drug Classl-Thyroxine
Synonyms for LEVOXYL
(-)-Thyroxine
(125I)T4
(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid
(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid
(S)-2-amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoic acid
002T595
1373931-44-2
1hk1
1hk2
1hk3
1hk4
1hk5
1y0x
2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]-propanoic acid
24486-40-6
2ceo
3-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)alanine
3-[4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-L-alanine
3,3',5,5'-Tetraiodo-L-thyronine
3,3',5,5''-Tetraiodo-L-thyronine
3,3'',5,5''-tetraiodo-L-thyronine
3,5,3',5'-Tetraiodo-L-thyronine
3,5,3',5'-Tetraiodothyronine
3,5,3'',5''-tetraiodo-L-thyronine
3,5,3'5'-Tetraiodo-L-thyronine
4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine
51-48-9
587-29-1
587-30-4
60833-83-2
7200-84-2
74-16-8
7U4LEE5872
AB00052176_09
AB00052176_10
AB00052176-08
AB0010528
AB2000689
AC-10465
AC-7504
AC1L1L7K
AK-40208
AKOS015905129
AM83594
AN-15421
AN-8921
AX8015809
BC630681
BDBM50301375
beta-((3,5-Diiodo-4-hydroxyphenoxy)-3,5-diiodophenyl)alanine
BIDD:PXR0161
bmse000923
BPBio1_000360
BRD-K30685142-001-05-5
BRD-K30685142-001-08-9
BRN 2228515
BSPBio_000326
BSPBio_002142
C01829
C15H11I4NO4
CAS-51-48-9
CCG-38738
CCRIS 6739
CHEBI:18332
CHEMBL1624
CHM0030272
CPD000059176
CS-1819
CT-230
CTK2H7538
D08125
DB-006261
DB00451
DivK1c_006967
DL-Thyroxin
DSSTox_CID_3214
DSSTox_GSID_23214
DSSTox_RID_76927
DTXSID8023214
EINECS 200-101-1
eltroxin
Epitope ID:123889
Eutirox
Forthyron (TN)
FT-0600821
GP9966
GTPL2635
Henning
HMS1569A08
HMS1921I06
HMS2090P18
HMS2092K12
HMS2096A08
HMS2233J18
HMS3259M11
HMS3713A08
HSDB 3108
HY-18341
J10324
KB-53412
KBio1_001911
KBio2_001556
KBio2_004124
KBio2_006692
KBio3_001642
KBioGR_000516
KBioSS_001556
KS-00000HDI
L-3,5,3',5'-Tetraiodothyronine
L-T4
L-Thryoxin
L-Thyroxin
L-thyroxine
L-Thyroxine (T4) solution, 100 mug/mL in methanol with 0.1N NH3, ampule of 1 mL, certified reference material
L-Thyroxine, >=98% (HPLC)
L-Thyroxine, 97+%
L-Thyroxine, free acid
L-Thyroxine, powder, BioReagent, suitable for cell culture
L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-
Laevothyroxinum
Laevothyroxinum (acid)
levothroid
Levothroid (*Sodium salt*)
Levothyroxin
levothyroxine
Levothyroxine (BAN)
Levothyroxine [INN:BAN]
Levothyroxine sodium
Levothyroxine Sodium (L-thyroxine)
Levothyroxine, Pharmaceutical Secondary Standard; Certified Reference Material
Levothyroxine, United States Pharmacopeia (USP) Reference Standard
Levothyroxinum
Levothyroxinum (acid)
LS-158291
LT4
MFCD00002595
MLS000028647
MLS002548901
MolPort-003-666-820
NC00485
NCGC00094852-03
NCGC00164336-01
NCGC00164336-02
NCGC00164336-03
NCGC00164336-05
NCGC00164336-06
NCGC00255368-01
NSC 36397
NSC-757434
NSC757434
O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine
O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine
O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine
Pharmakon1600-01500774
Prestwick_548
Prestwick0_000403
Prestwick1_000403
Prestwick2_000403
Prestwick3_000403
Q51BO43MG4
s2599
SAM002264651
SBI-0051608.P002
SCHEMBL23098
SDCCGMLS-0066571.P001
SMR000059176
SPBio_000386
SPBio_002265
SpecPlus_000871
Spectrum_001076
SPECTRUM1500774
Spectrum2_000573
Spectrum3_000611
Spectrum4_000128
Spectrum5_001500
SR-01000759430
SR-01000759430-2
SR-05000001567
SR-05000001567-1
ST24047479
SW196731-3
synthroid
Synthroid (*Sodium salt*)
Synthroid sodium
T-3850
t4
T4 (Hormone)
T4 levothyroxine
T44
Tetraiodothyronine
Tetramet
Thryroxine, l-
THX
Thyratabs
Thyrax
Thyreoideum
thyroxin
Thyroxinal
thyroxine
Thyroxine (l)
Thyroxine (T4), IRMM(R) certified Reference Material
Thyroxine (VAN)
Thyroxine [BAN]
Thyroxine I 125
Thyroxine iodine
Thyroxine, L-
Thyroxine, L- (8CI)
Thyroxine, labeled with iodine-125
Tox21_112101
Tox21_112101_1
Tox21_302156
TR-031344
Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, labeled with iodine-125
UNII-7U4LEE5872
UNII-Q51BO43MG4
UNII-QR0BV3BRIA component XUIIKFGFIJCVMT-LBPRGKRZSA-N
XUIIKFGFIJCVMT-LBPRGKRZSA-N
ZINC3830993

US Patents and Regulatory Information for LEVOXYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-011 May 25, 2001 AB1,AB3 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-010 May 25, 2001 AB1,AB3 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-011 May 25, 2001 AB1,AB3 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
QuintilesIMS
UBS
Healthtrust
Federal Trade Commission
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.